Clinical Trial Update: Luspatercept + Darbepoetin in MDS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of luspatercept and darbepoetin in myelodysplastic syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)
• REBLOZYL (LUSPATERCEPT)

Snippet

Sponsor: Yale University | Conditions: MDS (Myelodysplastic Syndrome) | Phase 2 | Status: RECRUITING